IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 256 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $133 | -35.4% | 29,200 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $206 | +35.5% | 29,200 | +17.3% | 0.00% | 0.0% |
| Q1 2023 | $152 | -4.4% | 24,900 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $159 | -99.9% | 24,900 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $239,000 | -13.1% | 24,900 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $275,000 | -33.7% | 24,900 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $415,000 | -12.6% | 24,900 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $475,000 | -22.6% | 24,900 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $614,000 | -5.2% | 24,900 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $648,000 | -17.8% | 24,900 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $788,000 | -31.8% | 24,900 | 0.0% | 0.00% | -42.9% |
| Q4 2020 | $1,155,000 | +71.1% | 24,900 | +21.5% | 0.01% | +40.0% |
| Q3 2020 | $675,000 | -40.1% | 20,500 | -50.0% | 0.01% | 0.0% |
| Q2 2020 | $1,126,000 | – | 41,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
| Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
| GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
| Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
| Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
| Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
| Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
| Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
| ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |